Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

EPA/IPN stock hub

EPA/IPN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/IPNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.7B

Euronext Paris

Market data

Live price

Current market quote for this ticker.

Current price

EPA/IPN

In the news

Latest news · EPA/IPN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.2

P25 8.5P50 12.2P75 17.3

Trailing P/E31.3

P25 14.7P50 19.3P75 30.4

ROE10.4

P25 -68.7P50 -23.2P75 6.6

ROIC20.9

P25 -59.8P50 -7.8P75 6.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/IPN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

247

Groups with data

Currency

EUR

Showing 247 of 247 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	5,535
Employees Change	177%
Employees Change Percent	3.3
Enterprise value	EUR 13.1B
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	FR0010259150
Last refreshed	2026-05-10
Market cap	EUR 13.7B
Price	EUR 166
Price currency	EUR
Rev Per Employee	709,882.57x
Sector	Healthcare
Sic	2834
Symbol	epa/IPN
Website	https://www.ipsen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.25%
EV Earnings	29.55x
EV/EBIT	12.77x
EV/EBITDA	9.59x
EV/FCF	12.68x
EV/Sales	3.34x
FCF yield	7.56%
Forward P/E	12.16x
P/B ratio	3.15x
P/E ratio	31.28x
P/S ratio	3.48x
PE Ratio10 Y	15.87x
PE Ratio3 Y	20.7x
PE Ratio5 Y	18.73x
PEG ratio	2.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.14%
EBITDA Margin	34.11%
FCF margin	26.3%
Gross margin	80.89%
Gross Profit	EUR 3.2B
Gross Profit Growth	1.46%
Gross Profit Growth Q	9.15%
Gross Profit Growth3 Y	4.61%
Gross Profit Growth5 Y	3.87%
Net Income	EUR 443.5M
Net Income Growth	28.22%
Net Income Growth Q	-3.86%
Net Income Growth Years	1%
Net Income Growth3 Y	-12.53%
Net Income Growth5 Y	-7.32%
Pretax Margin	14.71%
Profit Margin	11.29%
Profit Per Employee	EUR 80,126
Profitable Years	6
ROA	9.6
Roa5y	9.79
ROCE	18.68
ROE	10.44
Roe5y	16.41
ROIC	20.89
Roic5y	22.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.71%
Cagr15y	14.65%
Cagr1y	64.75%
Cagr20y	10.15%
Cagr3y	15.35%
Cagr5y	17.01%
Div CAGR10	6.53%
Div CAGR3	10.06%
Div CAGR5	9.86%
EPS Growth	28.19
EPS Growth Q	-3.87
EPS Growth Years	1
EPS Growth3 Y	-12.49
EPS Growth5 Y	-7.38
FCF Growth	39.14%
FCF Growth Q	67.23%
FCF Growth3 Y	10.84%
FCF Growth5 Y	3.39%
OCF Growth	24.35%
OCF Growth Q	36.09%
OCF Growth10 Y	4.56%
OCF Growth3 Y	8.79%
OCF Growth5 Y	3.22%
Revenue Growth	9.92x
Revenue Growth Q	9.29x
Revenue Growth Quarters	4x
Revenue Growth Years	5x
Revenue Growth3 Y	5.24x
Revenue Growth5 Y	4.48x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.59
Assets	EUR 6.9B
Cash	EUR 1.5B
Current Assets	EUR 2.8B
Current Liabilities	EUR 1.4B
Debt	EUR 970.4M
Debt EBITDA	EUR 0.71
Debt Equity	EUR 0.22
Debt FCF	EUR 0.94
Equity	EUR 4.3B
Interest Coverage	28.45
Liabilities	EUR 2.6B
Long Term Assets	EUR 4.1B
Long Term Liabilities	EUR 1.2B
Net Cash	EUR 556.1M
Net Cash By Market Cap	EUR 4.07
Net Cash Growth	239.91%
Net Debt EBITDA	EUR -0.41
Net Debt Equity	EUR -0.13
Net Debt FCF	EUR -0.54
Tangible Book Value	EUR 1.4B
Tangible Book Value Per Share	EUR 17.11
WACC	5.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.96
Inventory Turnover	2.85
Net Working Capital	EUR -6M
Quick ratio	1.69
Working Capital	EUR 1.4B
Working Capital Turnover	EUR 4.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.02%
Dividend Growth	14.29%
Dividend Growth Years	1%
Dividend per share	EUR 1.4
Dividend Years	21
Dividend Yield	0.84%
Ex Div Date	2026-06-03
Last Dividend	EUR 1.6
Payout Frequency	Annual
Payout Ratio	26.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	261.26%
1Y total return	64.7%
200-day SMA	132.6
3Y total return	53.49%
50-day SMA	160.8
50-day SMA vs 200-day SMA	50over200
5Y total return	119.34%
All Time High	173.5
All Time High Change	-4.09%
All Time High Date	2026-05-06
All Time Low	17.5
All Time Low Change	850.86%
All Time Low Date	2012-07-11
ATR	3.94
Beta	0.33
Beta1y	0.96
Beta2y	0.56
Ch YTD	39.83
High	169
High52	173.5
High52 Date	2026-05-06
High52ch	-4.09%
Low	165.3
Low52	99
Low52 Date	2025-05-12
Low52ch	68.08%
Ma50ch	3.45%
Price vs 200-day SMA	25.46%
RSI	53.91
RSI Monthly	72.65
RSI Weekly	66.38
Sharpe ratio	1.91x
Sortino ratio	3.47
Total Return	0.86%
Tr YTD	39.83
Tr15y	677.04%
Tr1m	1.53%
Tr1w	-0.06%
Tr3m	22.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1B
Operating Income Growth	0.12
Operating Income Growth Q	0.23
Operating Income Growth3 Y	10.06
Operating Income Growth5 Y	1.7
Operating margin	26.14

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	29,663,658%
Net Borrowing	476,900,000
Shares Insiders	26.85%
Shares Institutions	15.29%
Shares Out	82,099,856
Shares Qo Q	-0.3%
Shares Yo Y	-0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 994.1M
Average Volume	121,374.55x
Bv Per Share	52.47
CAPEX	EUR -105M
Ch10y	223.2
Ch15y	505.1
Ch1m	1.53
Ch1w	-0.06
Ch1y	62.5
Ch20y	389.3
Ch3m	22.26
Ch3y	48.31
Ch5y	106.8
Ch6m	34.41
Change	-1.25%
Change From Open	-1.07
Close	168.5
Days Gap	-0.18
Depreciation Amortization	313,200,000
Dollar Volume	15,431,270.4
Earnings Date	2026-04-23
EBIT	EUR 1B
EBITDA	EUR 1.3B
EPS	EUR 5.32
F Score	5
FCF	EUR 1B
FCF EV Yield	7.88x
FCF Per Share	EUR 12.59
Financing CF	298,400,000
Fiscal Year End	December
Founded	1,929
Goodwill	633,800,000
Graham Number	80.12727
Graham Upside	-51.85
Income Tax	EUR 133.6M
Investing CF	-615,200,000
Is Primary Listing	1
Last Earnings Date	2026-04-23
Last Report Date	2025-12-31
Lynch Fair Value	EUR 27.01
Lynch Upside	-83.77
Ma150	138.9
Ma150ch	19.76%
Ma20	165.2
Ma20ch	0.76%
Net CF	844,000,000
Next Earnings Date	2026-07-30
Open	168.2
P FCF Ratio	13.22
P OCF Ratio	12
Payment Date	2026-06-05
Position In Range	29.73
Ppne	668,000,000
Price Date	2026-05-08
Price EBITDA	EUR 10.19
Ptbv Ratio	9.66
Relative Volume	0.79x
Revenue	3,929,200,000x
SBC By Revenue	1x
Share Based Comp	39,300,000
Tax By Revenue	3.4x
Tax Rate	23.11%
Tr20y	590.91%
Tr6m	34.41%
Volume	92,736
Z Score	3.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

EPA/IPN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$1.40 annual per share

Payout ratio

+26.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+9.9%

1 consecutive years of growth

Total shareholder yield

+0.9%

Next ex-dividend date: 2026-06-03

Performance

EPA/IPN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EPA/IPN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.3%

Share of float held by funds and institutions

Insider ownership

+26.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

EPA/IPN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.9

Neutral momentum band

Price vs 200-day MA

+25.5%

50/200-day relationship not available

Beta (5Y)

0.33

Less volatile than the market

Sharpe ratio

1.91

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/IPN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/IPN stock rating?

epa/IPN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/IPN analysis?

The full report lives at /stocks/epa/IPN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/IPN?

The latest report frames epa/IPN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/IPN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.